Phase 1 study: New medicine extends t... - Advanced Prostate...
Phase 1 study: New medicine extends terminally-ill cancer patients' lives
Written by
rsgdmd
To view profiles and participate in discussions please or .
8 Replies
•
I don’t think it states which cancer it was effective on
Says they are about to start testing it on Sarcomas and Ovarian Cancer
Cancer Here, Cancer there................. Cancer everywhere makes me Swear (fucking Cancer).............. s
Good Luck, Good Health and Good Humor.
j-o-h-n Monday 03/27/2023 1:12 PM DST
similar to most of the other drugs now available only 1 in 20 was cancer free at 2 years, for others it looks like the drug only worked for a short time.
Progress none the less. A cure is coming.
Not what you're looking for?
You may also like...
Phase 1-2 study for niclosamide-based drug:
…thought they made cars… 😜
“Hyundai’s formulation claims to have a high enough drug concentration...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of...
Second generation selective PARP inhibitor: PETRANHA: Phase 1/2 study of AZD5305 + novel hormonal agents in patients mPCa
...as I reported, one of the patients on the trial (with ATM mutation) had a 100% remission......
Phase 1 study SBRT for bone metastases in oligometastatic patients. So far, "few toxicity events and high local control rate"
stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients:...
JAMA October 2108 - Does Complementary Medicine Increase Risk of Death for Cancer Patients?
On a subject that consumes a lot of written space on any post that suggest alternative treatments...